False positive seroreactivity to brucellosis in tuberculosis patients

A prevalence study

Mojtaba Varshochi, Jafar Majidi, Marjan Amini, Kamyar Ghabili, Mohammadali Mohajel Shoja

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Background: The rising worldwide incidence of tuberculosis (TB) increases the demand for knowledge about its potential seroreactivity with other microbial agents. A few reports and the authors' experiences indicate that tuberculosis may result in a false-positive brucellosis serology. This may cause a diagnostic challenge because of the close clinical resemblance of these two infections. Objective: The aim of the present prevalence study was to elucidate brucellosis seroreactivity in patients with active TB. Methods: Ninety-eight patients with newly diagnosed and active TB were studied using an enzyme-linked immunosorbent assay (ELISA) and Wright's and Coombs-Wright's tests. Seventy-five healthy individuals were used as controls. The patients showed signs of recovery after starting a standard anti-TB regimen and had no clinical evidence of brucellosis at a subsequent 6-month follow-up. The data were analyzed statistically by Fisher's exact test using SPSS 11.0. Results: We found that 9.2% of TB patients versus 1.3% of healthy controls had positive results on the anti-Brucella IgG ELISA (P = 0.04). Five TB patients were found to have agglutination on Wright's tests, while none of the controls showed agglutination. Conclusion: Active TB patients may have some seroreactivity with Brucella antigens, and Brucella IgG ELISA may give a false positive in these patients. Clinicians should consider false positive brucellosis seroreactivity in patients with active TB.

Original languageEnglish (US)
Pages (from-to)207-210
Number of pages4
JournalInternational Journal of General Medicine
Volume4
DOIs
StatePublished - Mar 31 2011
Externally publishedYes

Fingerprint

Brucellosis
Tuberculosis
Cross-Sectional Studies
Brucella
Enzyme-Linked Immunosorbent Assay
Agglutination
Coombs Test
Serology
Immunoglobulin G
Antigens
Incidence

Keywords

  • Diagnosis
  • ELISA
  • False positive serology

ASJC Scopus subject areas

  • Medicine(all)

Cite this

False positive seroreactivity to brucellosis in tuberculosis patients : A prevalence study. / Varshochi, Mojtaba; Majidi, Jafar; Amini, Marjan; Ghabili, Kamyar; Mohajel Shoja, Mohammadali.

In: International Journal of General Medicine, Vol. 4, 31.03.2011, p. 207-210.

Research output: Contribution to journalArticle

Varshochi, Mojtaba ; Majidi, Jafar ; Amini, Marjan ; Ghabili, Kamyar ; Mohajel Shoja, Mohammadali. / False positive seroreactivity to brucellosis in tuberculosis patients : A prevalence study. In: International Journal of General Medicine. 2011 ; Vol. 4. pp. 207-210.
@article{cde7aafa83a64753b7bce7dfcd29d65e,
title = "False positive seroreactivity to brucellosis in tuberculosis patients: A prevalence study",
abstract = "Background: The rising worldwide incidence of tuberculosis (TB) increases the demand for knowledge about its potential seroreactivity with other microbial agents. A few reports and the authors' experiences indicate that tuberculosis may result in a false-positive brucellosis serology. This may cause a diagnostic challenge because of the close clinical resemblance of these two infections. Objective: The aim of the present prevalence study was to elucidate brucellosis seroreactivity in patients with active TB. Methods: Ninety-eight patients with newly diagnosed and active TB were studied using an enzyme-linked immunosorbent assay (ELISA) and Wright's and Coombs-Wright's tests. Seventy-five healthy individuals were used as controls. The patients showed signs of recovery after starting a standard anti-TB regimen and had no clinical evidence of brucellosis at a subsequent 6-month follow-up. The data were analyzed statistically by Fisher's exact test using SPSS 11.0. Results: We found that 9.2{\%} of TB patients versus 1.3{\%} of healthy controls had positive results on the anti-Brucella IgG ELISA (P = 0.04). Five TB patients were found to have agglutination on Wright's tests, while none of the controls showed agglutination. Conclusion: Active TB patients may have some seroreactivity with Brucella antigens, and Brucella IgG ELISA may give a false positive in these patients. Clinicians should consider false positive brucellosis seroreactivity in patients with active TB.",
keywords = "Diagnosis, ELISA, False positive serology",
author = "Mojtaba Varshochi and Jafar Majidi and Marjan Amini and Kamyar Ghabili and {Mohajel Shoja}, Mohammadali",
year = "2011",
month = "3",
day = "31",
doi = "10.2147/IJGM.S15120",
language = "English (US)",
volume = "4",
pages = "207--210",
journal = "International Journal of General Medicine",
issn = "1178-7074",
publisher = "Dove Medical Press Ltd.",

}

TY - JOUR

T1 - False positive seroreactivity to brucellosis in tuberculosis patients

T2 - A prevalence study

AU - Varshochi, Mojtaba

AU - Majidi, Jafar

AU - Amini, Marjan

AU - Ghabili, Kamyar

AU - Mohajel Shoja, Mohammadali

PY - 2011/3/31

Y1 - 2011/3/31

N2 - Background: The rising worldwide incidence of tuberculosis (TB) increases the demand for knowledge about its potential seroreactivity with other microbial agents. A few reports and the authors' experiences indicate that tuberculosis may result in a false-positive brucellosis serology. This may cause a diagnostic challenge because of the close clinical resemblance of these two infections. Objective: The aim of the present prevalence study was to elucidate brucellosis seroreactivity in patients with active TB. Methods: Ninety-eight patients with newly diagnosed and active TB were studied using an enzyme-linked immunosorbent assay (ELISA) and Wright's and Coombs-Wright's tests. Seventy-five healthy individuals were used as controls. The patients showed signs of recovery after starting a standard anti-TB regimen and had no clinical evidence of brucellosis at a subsequent 6-month follow-up. The data were analyzed statistically by Fisher's exact test using SPSS 11.0. Results: We found that 9.2% of TB patients versus 1.3% of healthy controls had positive results on the anti-Brucella IgG ELISA (P = 0.04). Five TB patients were found to have agglutination on Wright's tests, while none of the controls showed agglutination. Conclusion: Active TB patients may have some seroreactivity with Brucella antigens, and Brucella IgG ELISA may give a false positive in these patients. Clinicians should consider false positive brucellosis seroreactivity in patients with active TB.

AB - Background: The rising worldwide incidence of tuberculosis (TB) increases the demand for knowledge about its potential seroreactivity with other microbial agents. A few reports and the authors' experiences indicate that tuberculosis may result in a false-positive brucellosis serology. This may cause a diagnostic challenge because of the close clinical resemblance of these two infections. Objective: The aim of the present prevalence study was to elucidate brucellosis seroreactivity in patients with active TB. Methods: Ninety-eight patients with newly diagnosed and active TB were studied using an enzyme-linked immunosorbent assay (ELISA) and Wright's and Coombs-Wright's tests. Seventy-five healthy individuals were used as controls. The patients showed signs of recovery after starting a standard anti-TB regimen and had no clinical evidence of brucellosis at a subsequent 6-month follow-up. The data were analyzed statistically by Fisher's exact test using SPSS 11.0. Results: We found that 9.2% of TB patients versus 1.3% of healthy controls had positive results on the anti-Brucella IgG ELISA (P = 0.04). Five TB patients were found to have agglutination on Wright's tests, while none of the controls showed agglutination. Conclusion: Active TB patients may have some seroreactivity with Brucella antigens, and Brucella IgG ELISA may give a false positive in these patients. Clinicians should consider false positive brucellosis seroreactivity in patients with active TB.

KW - Diagnosis

KW - ELISA

KW - False positive serology

UR - http://www.scopus.com/inward/record.url?scp=84897367193&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84897367193&partnerID=8YFLogxK

U2 - 10.2147/IJGM.S15120

DO - 10.2147/IJGM.S15120

M3 - Article

VL - 4

SP - 207

EP - 210

JO - International Journal of General Medicine

JF - International Journal of General Medicine

SN - 1178-7074

ER -